Mark Cockerill
Impact in
-
- Colorectal Cancer Treatments and Studies
-
- Melanoma and MAPK Pathways
- Epigenetics and DNA Methylation
- PI3K/AKT/mTOR signaling in cancer
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
Papers in ⓘ
-
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 2
- Signaling Pathways in Disease 1
- Melanoma and MAPK Pathways 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Armelle Logié (1 shared paper)Richard O. Jenkins (1 shared paper)Paul D. Smith (2 shared papers)Paul Martin (1 shared paper)Barry R. Davies (1 shared paper)Jennifer S. McKay (1 shared paper)James R. Hitchin (2 shared papers)Jonathan Tugwood (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Biomarkers (1 paper)Journal of Medicinal Chemistry (1 paper)Cellular and Molecular Life Sciences (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United KingdomSwitzerlandFrance
In The Last Decade
Mark Cockerill
9 papers receiving 519 citations
Peers
Comparison fields: 5 of 75
- Oncology 169
- Molecular Biology 415
- Pathology and Forensic Medicine 82
- Cancer Research 34
- Hematology 24
Countries citing papers authored by Mark Cockerill
This map shows the geographic impact of Mark Cockerill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cockerill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cockerill more than expected).
Fields of papers citing papers by Mark Cockerill
This network shows the impact of papers produced by Mark Cockerill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cockerill. The network helps show where Mark Cockerill may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Cockerill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 322 | |
| 2 | 2013 | 50 | |
| 3 | 2013 | 43 | |
| 4 | 2003 | 32 | |
| 5 | 2015 | 28 | |
| 6 | 2015 | 27 | |
| 7 | 1983 | 26 | |
| 8 | 2005 | 2 | |
| 9 | 1998 | 1 |
About Mark Cockerill
Mark Cockerill is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Urology, Pharmaceutical Science and Epidemiology, having authored 9 papers that have together received 531 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (2 papers), Signaling Pathways in Disease (1 paper), Melanoma and MAPK Pathways (1 paper), Cancer therapeutics and mechanisms (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper), Genetics and Neurodevelopmental Disorders (1 paper) and Advancements in Transdermal Drug Delivery (1 paper). The work is most often cited by research in Oncology (169 citations), Molecular Biology (415 citations), Pathology and Forensic Medicine (82 citations), Cancer Research (34 citations) and Hematology (24 citations). Mark Cockerill has collaborated with scholars based in United Kingdom, Switzerland and France. Frequent co-authors include Armelle Logié, Richard O. Jenkins, Paul D. Smith, Paul Martin, Barry R. Davies, Jennifer S. McKay, James R. Hitchin, Jonathan Tugwood, Tim C. P. Somervaille and Daniel H. Wiseman. Their work appears in journals such as Molecular Cancer Therapeutics, Biomarkers, Journal of Medicinal Chemistry, Cellular and Molecular Life Sciences and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.